Skip to content

CLOVER HEALTH INVESTMENTS, CORP. /DE

Public company
Headquarters
JERSEY CITY, New Jersey
Ticker
CLOV
CIK
0001801170

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

6
6 appointments, 0 departures

Last event

Nov 4, 2026
Executive appointmentCFO appointed: Joseph Clay Thornton

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
CFOJoseph Clay ThorntonNov 4, 2026Appointed
Chief Accounting OfficerJoseph Frank OldakowskiNov 4, 2026Appointed
Class I director of the BoardSenator Robert G. TorricelliSep 25, 2026Appointed
Class III director of the BoardBrian J. Miller, M.D., M.B.A., M.P.H.Sep 25, 2026Appointed

Related companies

Same industry and state, with recent events.

  1. Executive appointment

    CFO appointed: Joseph Clay Thornton

    Joseph Clay Thornton was named Chief Financial Officer of CLOVER HEALTH INVESTMENTS, CORP. /DE, effective November 4, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Financial Officer

    Source: SEC 8-K, filed Nov 4, 2026

  2. Executive appointment

    Chief Accounting Officer appointed: Joseph Frank Oldakowski

    Joseph Frank Oldakowski was named Chief Accounting Officer of CLOVER HEALTH INVESTMENTS, CORP. /DE, effective November 4, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Accounting Officer

    Source: SEC 8-K, filed Nov 4, 2026

  3. Executive appointment

    Class I director of the Board appointed: Senator Robert G. Torricelli

    Senator Robert G. Torricelli was named Class I director of the Board of CLOVER HEALTH INVESTMENTS, CORP. /DE, effective September 22, 2026. The company reported the change in an 8-K/A that cites Item 5.02.

    Role: Class I director of the Board

    Source: SEC 8-K, filed Sep 25, 2026

  4. Executive appointment

    Class III director of the Board appointed: Brian J. Miller, M.D., M.B.A., M.P.H.

    Brian J. Miller, M.D., M.B.A., M.P.H. was named Class III director of the Board of CLOVER HEALTH INVESTMENTS, CORP. /DE, effective September 22, 2026. The company reported the change in an 8-K/A that cites Item 5.02.

    Role: Class III director of the Board

    Source: SEC 8-K, filed Sep 25, 2026

  5. Executive appointment

    Class I director of the Board appointed: Senator Robert G. Torricelli

    Senator Robert G. Torricelli was named Class I director of the Board of CLOVER HEALTH INVESTMENTS, CORP. /DE, effective September 22, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Class I director of the Board

    Source: SEC 8-K, filed Sep 24, 2026

  6. Executive appointment

    Class III director of the Board appointed: Brian J. Miller, M.D., M.B.A., M.P.H.

    Brian J. Miller, M.D., M.B.A., M.P.H. was named Class III director of the Board of CLOVER HEALTH INVESTMENTS, CORP. /DE, effective September 22, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Class III director of the Board

    Source: SEC 8-K, filed Sep 24, 2026

  7. WARN notice

    WARN notice: Jersey City, NJ

    Clover Health filed a WARN notice with the New Jersey WARN list covering 64 workers in Jersey City. The layoffs take effect on May 28, 2019.

    Site: Jersey City, NJ

    Workers affected: 64

    Source: New Jersey WARN list, filed May 28, 2019

  8. layoffs from May 28, 2019

    WARN notice

    WARN notice: San Francisco, CA

    Clover Health Labs, LLC filed a WARN notice with the California WARN list on Mar 27, 2019 covering 49 workers in San Francisco. The layoffs take effect on May 28, 2019.

    Site: San Francisco, CA

    Workers affected: 49

    Source: California WARN list, filed Mar 27, 2019

Last verified Nov 8, 2026